Treatment with OVA + CD8α ALN-1 caused a significant delay in tumor growth over the treatment period (figure 1C, D), however, tumor control was transient and volumes rapidly caught up with lesion sizes observed in controls on treatment discontinuation. The gene discussed is CD8A; the disease is neoplasm.